Andreas R. Baudy

mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells

Raju V. Pusapati, Anneleen Daemen, Catherine Wilson et al. · Cancer Cell · 2016 · 232 citations · Full text

Medicine, Cancer Biology, Oncology +16

FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973

Andreas R. Baudy, Taner Dogan, Judith E Flores-Mercado et al. · EJNMMI Research · 2012 · 62 citations · Full text

Medicine, Oncology, Pharmacology +16

A robust in vitro screening assay to identify NF-κB inhibitors for inflammatory muscle diseases

Andreas R. Baudy, Nandita Saxena, Heather Gordish et al. · International Immunopharmacology · 2009 · 31 citations

Medicine, Immunology, Pharmacology +14

Non-invasive Optical Imaging of Muscle Pathology in mdx Mice Using Cathepsin Caged Near-Infrared Imaging

Andreas R. Baudy, Arpana Sali, Sarah Jordan et al. · Molecular Imaging and Biology · 2010 · 30 citations · Full text

Medicine, Biomedical Sciences, Pathology +17

Δ-9,11 Modification of Glucocorticoids Dissociates Nuclear Factor-κB Inhibitory Efficacy from Glucocorticoid Response Element-Associated Side Effects

Andreas R. Baudy, Erica Reeves, Jesse M. Damsker et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 30 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15